The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

Taispeáin leaganacha eile (1)

Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D
Formáid:	Conference item
Foilsithe / Cruthaithe:	Springer London 2018

Míreanna comhchosúla

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
de réir: Ali, M, et al.
Foilsithe / Cruthaithe: (2018)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
de réir: Ali, MS, et al.
Foilsithe / Cruthaithe: (2017)

Oral bisphosphonates and chronic kidney disease: progression and safety
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2018)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
de réir: Alarkawi, D, et al.
Foilsithe / Cruthaithe: (2018)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
de réir: Robinson, DE, et al.
Foilsithe / Cruthaithe: (2021)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
de réir: Strauss, V, et al.
Foilsithe / Cruthaithe: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
de réir: Robinson, DE, et al.
Foilsithe / Cruthaithe: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
de réir: Robinson, DE, et al.
Foilsithe / Cruthaithe: (2021)

Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
de réir: Alarkawi, D, et al.
Foilsithe / Cruthaithe: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
de réir: Ali, M, et al.
Foilsithe / Cruthaithe: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
de réir: Danielle E Robinson, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
de réir: Veronika Kreutle, et al.
Foilsithe / Cruthaithe: (2014-06-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
de réir: Hawley, S, et al.
Foilsithe / Cruthaithe: (2014)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
de réir: Ryan Jalleh, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Denosumab and chronic kidney disease: Severe life-threatening hypocalcaemia
de réir: Pilar Monge Rafael, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2014)

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
de réir: Ali, MS, et al.
Foilsithe / Cruthaithe: (2020)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
de réir: Abrahamsen, B, et al.
Foilsithe / Cruthaithe: (2016)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
de réir: Oda, T, et al.
Foilsithe / Cruthaithe: (2021)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
de réir: Round, G, et al.
Foilsithe / Cruthaithe: (2012)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
de réir: Round, G, et al.
Foilsithe / Cruthaithe: (2012)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
de réir: Reyes, C, et al.
Foilsithe / Cruthaithe: (2015)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2012)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
de réir: Jean-Jacques Body, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
de réir: Rodriguez, AJ, et al.
Foilsithe / Cruthaithe: (2020)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
de réir: Garriga, C, et al.
Foilsithe / Cruthaithe: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
de réir: Garriga, C, et al.
Foilsithe / Cruthaithe: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
de réir: Garriga, C, et al.
Foilsithe / Cruthaithe: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
de réir: Garriga, C, et al.
Foilsithe / Cruthaithe: (2017)

Vitamin D repletion and aromatase inhibitor-related bone loss in women non treated with bisphosphonates
de réir: Prieto-Alhambra, D, et al.
Foilsithe / Cruthaithe: (2011)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
de réir: Khalid, S, et al.
Foilsithe / Cruthaithe: (2021)

HYPOCALCAEMIA – CASE REPORT
de réir: Tina Svetlik, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Pseudohypoparathyroidism, Rare Cause of Hypocalcaemia!
de réir: Rupal V. Dosi, et al.
Foilsithe / Cruthaithe: (2013-10-01)